Effect of Vitamin D Supplementation on Blood Pressure in Elderly People
Primary Purpose
High Blood Pressure
Status
Completed
Phase
Phase 2
Locations
Mexico
Study Type
Interventional
Intervention
Calcitriol
Control
Sponsored by

About this trial
This is an interventional treatment trial for High Blood Pressure focused on measuring elderly people, high blood pressure, vitamin D.
Eligibility Criteria
Inclusion Criteria:
- Adults aged ≥ 60 years with essential hypertension.
- Subjects on anti-hypertensive for more than 10 years and the dosages were unchanged during the study.
Exclusion Criteria:
- Subjects who had been treated with vitamin D within the last three months.
- None were on hormone replacement therapy.
Sites / Locations
- Facultad de Medicina-Universidad de Colima
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Calcitriol
Control
Arm Description
A daily dose of 1000 IU of cholecalciferol (administered as 1 capsule of 25 μg each)
A daily dose of placebo (administered as 1 capsule )
Outcomes
Primary Outcome Measures
Difference of systolic and diastolic blood pressure
Difference between systolic and diastolic blood pressure before and after treatment.
Secondary Outcome Measures
Difference of Serum 25-Hidroxyvitamin-D
Difference between 25-Hidroxyvitamin-D before and after treatment.
Full Information
NCT ID
NCT02047799
First Posted
January 26, 2014
Last Updated
November 8, 2017
Sponsor
Universidad de Colima
1. Study Identification
Unique Protocol Identification Number
NCT02047799
Brief Title
Effect of Vitamin D Supplementation on Blood Pressure in Elderly People
Official Title
Effect of Vitamin D Supplementation on Blood Pressure in Elderly People
Study Type
Interventional
2. Study Status
Record Verification Date
November 2017
Overall Recruitment Status
Completed
Study Start Date
April 2013 (undefined)
Primary Completion Date
April 2013 (Actual)
Study Completion Date
June 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Universidad de Colima
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The prevalence and incidence of cardiovascular disease (such as Hypertension) increases exponentially with age (McDermott, 2007;) These diseases account for 30% of the global mortality (WHO, 2011). Vitamin D (VD) insufficiency affects as many as half of otherwise healthy adults in developed countries (Holick, 2007). VD is implicated in the control of blood pressure (BP) through inhibition of the renin-angiotensin system (Yamshchikov, 2009), although the role of VD supplementation for prevention and treatment of the HTA is controversial.The purpose of this study was to investigate if VD supplement in elderly people reduces the levels of BP.
Detailed Description
Study population Adults aged ≥ 60 years with essential hypertension were recruited through nursing homes and physical activity groups in the state of Colima, México. 45 subjects were assessed for eligibility at our out-patient clinic. We excluded subjects with impaired renal or hepatic function; also subjects who had been treated with vitamin D within the last three months.
None were on hormone replacement therapy, but we included subjects on anti-hypertensive for more than 10 years and the dosages were unchanged during the study. Before randomization, two subjects withdrew the informed consent because of personal reasons, and two subjects were excluded due to the diagnosis of severe hypertension.
Design The design was a double-blind, placebo controlled randomized clinical trial. The participants were randomly assigned using a computer-generated randomization code into two groups: group 1 (calcitriol group)with 22 subjects whom were enrolled for 6 weeks of treatment with a daily dose of 1000 IU of cholecalciferol (administered as 1 capsule of 25 μg each) and group 2 with 23 subjects (control group) whom received a similar placebo tablet for also 6 weeks.
During treatment, nine subjects (20%) left the trial due to personal reasons. All patients provided written informed consent. The study was conducted in accordance with the Declaration of Helsinki II and the guidance on Good Clinical Practice (GCP). Approval was obtained from the bioethics committee of the Faculty of Medicine from the University of Colima (FM014/2012).
Measurement At the screening visit prior to randomization, subjects had a routine clinical examination and data concerning medical history. BP was measured 3 consecutive days at the same time, using a kit integrated aneroid sphygmomanometer with stethoscope (medimetrics 5769) with the patient seated and with at least 5 min rest. The subjects with average BP >140/90 mm Hg were included in the study.
Once enrolled in the study groups, anthropometrics measurements were collected. The measurements performed were weight and height with light clothing and no shoes, and the indicator body mass index (kg/m2) was calculated. For the determination of serum 25(OH)D,two blood samples were collected in the morning after an overnight fast of minimum 8 h on the day of the randomization and at the end of the study.
The patients attended control visits every week for safety measures, adverse event registration and assessment of compliance.Returned pills were counted at each visit, and compliance was calculated as the percentage of used pills compared to the expected number.
Biochemistry Serum 25(OH)D concentration were measured with the use of competitive enzyme-linked immunosorbent assay (ELISA: immunodiagnostic, Bernheim, Germany) after solid-phase extraction (reference range: 17-53 pg/mL). The intra- and interassay CVs for the 2 Vitamin D metabolites were <7,0% and 9,0%, respectively.
Statistical Analysis The data were analyzed with the SPSS version 21. The variables studied were described as frequencies, percentages and as median (interquartile range); inferential statistics were performed with non parametric tests (Mann Whitney and related sample Wilcoxon test), and correlations between variables were analyzed by bivariate correlation analysis by Pearson's correlation. Statistical significance was set at a p value < 0.05.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
High Blood Pressure
Keywords
elderly people, high blood pressure, vitamin D.
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
45 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Calcitriol
Arm Type
Active Comparator
Arm Description
A daily dose of 1000 IU of cholecalciferol (administered as 1 capsule of 25 μg each)
Arm Title
Control
Arm Type
Placebo Comparator
Arm Description
A daily dose of placebo (administered as 1 capsule )
Intervention Type
Dietary Supplement
Intervention Name(s)
Calcitriol
Intervention Description
Subjects whom were enrolled for 6 weeks of treatment with a daily dose of Calcitriol (1000 UI)
Intervention Type
Dietary Supplement
Intervention Name(s)
Control
Intervention Description
Subjects whom were enrolled for 6 weeks of treatment with a daily dose of Placebo
Primary Outcome Measure Information:
Title
Difference of systolic and diastolic blood pressure
Description
Difference between systolic and diastolic blood pressure before and after treatment.
Time Frame
6 weeks
Secondary Outcome Measure Information:
Title
Difference of Serum 25-Hidroxyvitamin-D
Description
Difference between 25-Hidroxyvitamin-D before and after treatment.
Time Frame
6 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adults aged ≥ 60 years with essential hypertension.
Subjects on anti-hypertensive for more than 10 years and the dosages were unchanged during the study.
Exclusion Criteria:
Subjects who had been treated with vitamin D within the last three months.
None were on hormone replacement therapy.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jaime A Bricio Barrios
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Carmen A Sánchez Ramírez, MD, PhD
Organizational Affiliation
Universidad de Colima
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Alín J Palacios Fonseca, MS
Organizational Affiliation
Universidad de Colima
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Mario del-Toro Equihua, PhD
Organizational Affiliation
Universidad de Colima
Official's Role
Study Chair
Facility Information:
Facility Name
Facultad de Medicina-Universidad de Colima
City
Colima
ZIP/Postal Code
28000
Country
Mexico
12. IPD Sharing Statement
Citations:
PubMed Identifier
17374819
Citation
McDermott MM. The international pandemic of chronic cardiovascular disease. JAMA. 2007 Mar 21;297(11):1253-5. doi: 10.1001/jama.297.11.1253. No abstract available.
Results Reference
background
Citation
WHO, World Heart Federation, World Stroke Organization. Global atlas on cardiovascular disease prevention and control. The Atlas of Heart Disease and Stroke. World Health Organization, 2011;8-13
Results Reference
background
PubMed Identifier
2825606
Citation
Holick MF, Smith E, Pincus S. Skin as the site of vitamin D synthesis and target tissue for 1,25-dihydroxyvitamin D3. Use of calcitriol (1,25-dihydroxyvitamin D3) for treatment of psoriasis. Arch Dermatol. 1987 Dec;123(12):1677-1683a.
Results Reference
background
PubMed Identifier
19491064
Citation
Yamshchikov AV, Desai NS, Blumberg HM, Ziegler TR, Tangpricha V. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract. 2009 Jul-Aug;15(5):438-49. doi: 10.4158/EP09101.ORR.
Results Reference
background
PubMed Identifier
27897610
Citation
Bricio-Barrios JA Rd, Palacios-Fonseca AJ MSc, Del Toro-Equihua M, Sanchez-Ramirez CA. Effect of Calcitriol Supplementation on Blood Pressure in Older Adults. J Nutr Gerontol Geriatr. 2016 Oct-Dec;35(4):243-252. doi: 10.1080/21551197.2016.1206499.
Results Reference
derived
Learn more about this trial
Effect of Vitamin D Supplementation on Blood Pressure in Elderly People
We'll reach out to this number within 24 hrs